JP2008540557A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008540557A5 JP2008540557A5 JP2008511333A JP2008511333A JP2008540557A5 JP 2008540557 A5 JP2008540557 A5 JP 2008540557A5 JP 2008511333 A JP2008511333 A JP 2008511333A JP 2008511333 A JP2008511333 A JP 2008511333A JP 2008540557 A5 JP2008540557 A5 JP 2008540557A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- ether group
- ether
- compound represented
- atom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67978505P | 2005-05-11 | 2005-05-11 | |
| PCT/US2006/018153 WO2006122216A2 (en) | 2005-05-11 | 2006-05-11 | Processes for production of phenolic 4-biphenylylazetidin-2-ones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008540557A JP2008540557A (ja) | 2008-11-20 |
| JP2008540557A5 true JP2008540557A5 (https=) | 2009-08-13 |
Family
ID=37397290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008511333A Pending JP2008540557A (ja) | 2005-05-11 | 2006-05-11 | フェノール型４−ビフェニリルアゼチジン−２−オンの製造方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080200669A1 (https=) |
| EP (1) | EP1885703A4 (https=) |
| JP (1) | JP2008540557A (https=) |
| KR (1) | KR20080017345A (https=) |
| CN (1) | CN101218213A (https=) |
| AU (1) | AU2006244043A1 (https=) |
| BR (1) | BRPI0608970A2 (https=) |
| CA (1) | CA2608075A1 (https=) |
| EA (1) | EA200702464A1 (https=) |
| IL (1) | IL187287A0 (https=) |
| MA (1) | MA29539B1 (https=) |
| MX (1) | MX2007014172A (https=) |
| NO (1) | NO20076371L (https=) |
| WO (1) | WO2006122216A2 (https=) |
| ZA (1) | ZA200710721B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0215579D0 (en) | 2002-07-05 | 2002-08-14 | Astrazeneca Ab | Chemical compounds |
| ATE369335T1 (de) * | 2003-11-10 | 2007-08-15 | Microbia Inc | 4-biarylyl-1-phenylazetidin-2-one |
| ATE485267T1 (de) | 2003-12-23 | 2010-11-15 | Astrazeneca Ab | Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung |
| TW200726746A (en) * | 2005-05-06 | 2007-07-16 | Microbia Inc | Processes for production of 4-biphenylylazetidin-2-ones |
| MX2007014162A (es) * | 2005-05-09 | 2008-04-04 | Microbia Inc | Agentes de acoplamiento de bencenfosfonatos organometalicos. |
| JP2008545700A (ja) * | 2005-05-25 | 2008-12-18 | マイクロビア インコーポレーテッド | ４−（ビフェニリル）アゼチジン−２−オンホスホン酸類の製造方法 |
| UY29607A1 (es) | 2005-06-20 | 2007-01-31 | Astrazeneca Ab | Compuestos quimicos |
| SA06270191B1 (ar) | 2005-06-22 | 2010-03-29 | استرازينيكا ايه بي | مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم |
| AR057072A1 (es) | 2005-06-22 | 2007-11-14 | Astrazeneca Ab | Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto |
| TW200811098A (en) | 2006-04-27 | 2008-03-01 | Astrazeneca Ab | Chemical compounds |
| EP2061767B1 (de) | 2006-08-08 | 2014-12-17 | Sanofi | Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung |
| EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102007054497B3 (de) | 2007-11-13 | 2009-07-23 | Sanofi-Aventis Deutschland Gmbh | Neue kristalline Diphenylazetidinonhydrate und Verfahren zu deren Herstellung |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
| US20120028340A1 (en) * | 2009-04-02 | 2012-02-02 | Piyush Suresh Lathi | Kinetic resolution of (4s) -- 4- phenyl -- 3- [(5rs)-5-(4-flurophenyl)-5- hydroxypentanoyl] --1,3-oxazolidin-2-one to the (5s) isomer via lipase catalyzed enantioselective esterification of the (5r) isomer |
| KR20120060207A (ko) | 2009-08-26 | 2012-06-11 | 사노피 | 신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도 |
| EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
| EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| WO2012120056A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| EP2766349B1 (de) | 2011-03-08 | 2016-06-01 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| EP2683704B1 (de) | 2011-03-08 | 2014-12-17 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
| CN102285932B (zh) * | 2011-09-01 | 2013-06-12 | 浙江大学 | 一种依替米贝中间体的制备方法 |
| AU2019318209B2 (en) | 2018-08-10 | 2025-09-25 | Diapin Therapeutics, Llc | Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2525125B2 (ja) * | 1991-07-23 | 1996-08-14 | シェリング・コーポレーション | 血清コレステロ―ル低下薬として有用な置換β−ラクタム化合物およびそれらの製法 |
| US5631365A (en) * | 1993-09-21 | 1997-05-20 | Schering Corporation | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| EP1137634B1 (en) * | 1998-12-07 | 2005-06-15 | Schering Corporation | Process for the synthesis of azetidinones |
| US6207822B1 (en) * | 1998-12-07 | 2001-03-27 | Schering Corporation | Process for the synthesis of azetidinones |
| IL156552A0 (en) * | 2000-12-21 | 2004-01-04 | Aventis Pharma Gmbh | Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use |
| EP1345895B1 (de) * | 2000-12-21 | 2006-12-27 | Sanofi-Aventis Deutschland GmbH | Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen |
| TWI291957B (en) * | 2001-02-23 | 2008-01-01 | Kotobuki Pharmaceutical Co Ltd | Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same |
| DK1373230T3 (da) * | 2001-03-28 | 2005-11-07 | Schering Corp | Enantiselektiv syntese af azetidinon mellemprodukter |
| EP1626954A2 (en) * | 2003-05-05 | 2006-02-22 | Ranbaxy Laboratories, Ltd. | Process for the preparation of trans-isomers of diphenylazetidinone derivatives |
| ATE369335T1 (de) * | 2003-11-10 | 2007-08-15 | Microbia Inc | 4-biarylyl-1-phenylazetidin-2-one |
| US20080194494A1 (en) * | 2005-04-26 | 2008-08-14 | Microbia, Inc. | 4-Biarylyl-1-Phenylazetidin-2-One Glucuronide Derivatives for Hypercholesterolemia |
| US20090131395A1 (en) * | 2005-05-05 | 2009-05-21 | Microbia, Inc. | Biphenylazetidinone cholesterol absorption inhibitors |
| TW200726746A (en) * | 2005-05-06 | 2007-07-16 | Microbia Inc | Processes for production of 4-biphenylylazetidin-2-ones |
-
2006
- 2006-05-11 MX MX2007014172A patent/MX2007014172A/es unknown
- 2006-05-11 WO PCT/US2006/018153 patent/WO2006122216A2/en not_active Ceased
- 2006-05-11 CA CA002608075A patent/CA2608075A1/en not_active Abandoned
- 2006-05-11 US US11/913,958 patent/US20080200669A1/en not_active Abandoned
- 2006-05-11 EA EA200702464A patent/EA200702464A1/ru unknown
- 2006-05-11 AU AU2006244043A patent/AU2006244043A1/en not_active Abandoned
- 2006-05-11 CN CNA2006800249696A patent/CN101218213A/zh active Pending
- 2006-05-11 EP EP06770192A patent/EP1885703A4/en not_active Withdrawn
- 2006-05-11 BR BRPI0608970-4A patent/BRPI0608970A2/pt not_active Application Discontinuation
- 2006-05-11 KR KR1020077028829A patent/KR20080017345A/ko not_active Withdrawn
- 2006-05-11 JP JP2008511333A patent/JP2008540557A/ja active Pending
-
2007
- 2007-11-11 IL IL187287A patent/IL187287A0/en unknown
- 2007-12-10 ZA ZA200710721A patent/ZA200710721B/xx unknown
- 2007-12-10 MA MA30463A patent/MA29539B1/fr unknown
- 2007-12-10 NO NO20076371A patent/NO20076371L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008540557A5 (https=) | ||
| JP2008545700A5 (https=) | ||
| JP2004536811A5 (https=) | ||
| JP2003520235A5 (https=) | ||
| JP2022544769A5 (https=) | ||
| JP2010510976A5 (https=) | ||
| JP2009534468A5 (https=) | ||
| JP2013538849A5 (https=) | ||
| JP2006509046A5 (https=) | ||
| JP2009538336A5 (https=) | ||
| JP2013520495A5 (https=) | ||
| JP2007524706A5 (https=) | ||
| JP2004528385A5 (https=) | ||
| RU2004126442A (ru) | Способ получения ингибиторов hmg-coa редуктазы | |
| JP2008542205A5 (https=) | ||
| JP5115477B2 (ja) | 水酸基を有する３−エチルオキセタン化合物及びその製法 | |
| JP2008526897A5 (https=) | ||
| JP2008520662A5 (https=) | ||
| JP2006514956A5 (https=) | ||
| JP2004018831A5 (https=) | ||
| JP2008503582A5 (https=) | ||
| JP2004010877A5 (https=) | ||
| JP2011513358A5 (https=) | ||
| JP2006512470A5 (https=) | ||
| JP5257353B2 (ja) | 置換ヒドロキシメチルフェノールの新規な合成 |